General (including evidence of efficacy) Immunosuppression following cardiac transplantation Heart transplantation is a well-established therapeutic option for patients with end-stage heart disease. The development of immunosuppressive agents has resulted in a dramatic improvement in the survival of heart transplant recipients, with 1- and 10-year survival rates approaching 90% and 50%, respectively. Despite this, there is a 25-30% risk of…
- Loading...
